EUVIMEDEUVIMED entdecken
Crossref

Curcumin and Neurocognitive Health: Mechanistic Insights and Translational Clinical Evidence

Suhas S, Preethi R, Vanitha Reddy P

International Journal of Biological Research · 15.04.2026 · 13 (1) · 1-7

DOI: 10.14419/06fd2p85 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Research, online erschienen am 15.04.2026. Verfasst von Suhas S und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurocognitive decline represents a growing public health concern, with limited disease-‎modifying therapeutic options currently available. Curcumin, a polyphenolic compound derived ‎from Curcuma longa, has attracted interest due to its proposed neuroprotective properties, ‎however, translating experimental findings into consistent clinical benefits remains uncertain. ‎This narrative review synthesises mechanistic, preclinical, and clinical evidence examining the ‎role of curcumin in neurocognitive health and highlights key translational challenges. ‎Experimental studies demonstrate modulation of oxidative stress, neuroinflammatory signalling, ‎amyloid aggregation, and neurotrophic pathways, supporting biological plausibility. Preclinical ‎models frequently report improvements in learning and memory, though effects often occur at ‎exposure levels not readily achievable in humans. Clinical evidence remains heterogeneous and ‎influenced by formulation, bioavailability, dosage, intervention duration, and cognitive ‎assessment methods. Conventional curcumin preparations generally show limited cognitive ‎benefit, whereas selected trials using enhanced-bioavailability formulations report modest ‎improvements, primarily in non-demented older adults. Curcumin supplementation is generally ‎well tolerated, although long-term safety data remain limited. Overall, despite compelling ‎mechanistic rationale, current clinical evidence is insufficient to support routine use of curcumin ‎for neurocognitive enhancement or treatment of neurodegenerative disease, underscoring the ‎need for rigorously designed trials using standardised formulations and robust cognitive and ‎biomarker-based outcomes‎.

Zitieren

APA

S, S., R, P., & P, V. R. (2026). Curcumin and Neurocognitive Health: Mechanistic Insights and Translational Clinical Evidence. International Journal of Biological Research, 13(1), 1-7. https://doi.org/10.14419/06fd2p85

Vancouver

S S, R P, P VR. Curcumin and Neurocognitive Health: Mechanistic Insights and Translational Clinical Evidence. International Journal of Biological Research. 2026;13(1):1-7. doi:10.14419/06fd2p85

BibTeX
@article{S2026,
  author = {S, Suhas and R, Preethi and P, Vanitha Reddy},
  title = {Curcumin and Neurocognitive Health: Mechanistic Insights and Translational Clinical Evidence},
  journal = {International Journal of Biological Research},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {1--7},
  doi = {10.14419/06fd2p85}
}
Kostenlos starten →